CANCER TESTIS ANTIGENS IN CANCER IMMUNOTHERAPY
Low toxicity, oncospecificity, immunogenicity and relatively frequent expression of CT antigens in many types of cancer justify their use in cancer immunotherapy. This review presents the data on CTA use in new clinical approaches to the malignant process control, developed from the ideas of the ant...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Russian Academy of Sciences, Tomsk National Research Medical Center
2017-06-01
|
| Series: | Сибирский онкологический журнал |
| Subjects: | |
| Online Access: | https://www.siboncoj.ru/jour/article/view/523 |